Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · Real-Time Price · USD
0.7220
-0.0877 (-10.83%)
At close: Nov 20, 2026, 4:00 PM EST
0.7216
-0.0004 (-0.06%)
After-hours: Nov 20, 2026, 4:15 PM EST
Sonoma Pharmaceuticals Employees
Sonoma Pharmaceuticals had 10 employees as of March 31, 2026. The number of employees increased by 2 or 25.00% compared to the previous year. That makes Sonoma Pharmaceuticals the 40,368th largest employer in the world and 6,072nd in the United States.
Employees
10
Change (1Y)
2
Growth (1Y)
25.00%
Revenue / Employee
$2,349,000
Profits / Employee
-$179,600
Market Cap
3.65M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 10 | 2 | 25.00% | 10 | 0 |
| Mar 31, 2025 | 8 | -2 | -20.00% | 8 | 0 |
| Mar 31, 2024 | 10 | 1 | 11.11% | 10 | 0 |
| Mar 31, 2023 | 9 | -3 | -25.00% | 9 | 0 |
| Mar 31, 2022 | 12 | -3 | -20.00% | 12 | 0 |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Universe Pharmaceuticals INC | 216 |
| Biofrontera | 94 |
| Sunshine Biopharma | 50 |
| cbdMD | 42 |
| RedHill Biopharma | 13 |
| Gelteq | 8 |
| PRF Technologies | 7 |
| Caring Brands | 3 |
SNOA News
- 7 days ago - Sonoma Pharmaceuticals files $46.65M mixed securities shelf - TheFly
- 3 months ago - Sonoma Pharmaceuticals reports Q1 EPS (9c) vs. (76c) last year - TheFly
- 3 months ago - Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA - Accesswire
- 4 months ago - Sonoma Pharmaceuticals receives 510(k) clearance for Microdacyn solution - TheFly
- 4 months ago - Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution - Accesswire
- 5 months ago - Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results - Accesswire
- 7 months ago - Sonoma Pharmaceuticals prices 2.96M shares at $1.35 in public offering - TheFly
- 7 months ago - Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering - Accesswire